Presentatie - vzw farmaka asbl
Presentatie - vzw farmaka asbl
Presentatie - vzw farmaka asbl
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Nitraten<br />
25.Heidenreich. JAMA 1999;281:1927-36<br />
Design N/n Population Sd Interventions Outcomes Results<br />
MA<br />
(search<br />
date<br />
N=72 Angina<br />
pectoris<br />
35%<br />
Mean: 8w β-blocker vs caantagonists<br />
Angina episodes/w Mean difference=0.31 (95%CI –<br />
0.62 to 0,0) in favour of β-<br />
blockers<br />
1997)<br />
previous<br />
Nitroglycerin use/w No difference<br />
MI<br />
Time to 1 mm ST↓ No difference<br />
N=6 Mean: 5w β-blockers vs nitrates Same outcomes No difference<br />
N=12 Mean: 3w Nitrates vs ca-antagonists Same outcomes No difference<br />
24.Perras. The use of nitrates in chronic stable angina. CCOHTA 1996<br />
Design N/n Population Sd Interventions Outcomes Results<br />
SR N=2,<br />
n=56<br />
Angina<br />
pectoris<br />
>12w Oral isosorbidedinitrate vs nitroglycerin patch Exercise time to<br />
angina<br />
No difference<br />
www.<strong>farmaka</strong>.be<br />
Project<br />
Farmaka